DNA microarray for genotyping antibiotic resistance determinants in Acinetobacter baumannii clinical isolates
Simon Dally1, Karin Lemuth, Martin Kaase
1Institute for Laboratory and Transfusion Medicine, Heart and Diabetes Center NRW, University Hospital of the Ruhr-University Bochum, Bad Oeynhausen, Germany.
Antimicrobial Agents and Chemotherapy
|July 17, 2013
Summary
A new microarray rapidly detects 91 antibiotic resistance targets in Acinetobacter baumannii within 4 hours. This rapid diagnostic tool aids in timely treatment decisions for critical patients and supports surveillance efforts.
Area of Science:
- Microbiology
- Molecular Diagnostics
- Infectious Diseases
Background:
- Acinetobacter baumannii is a significant global health concern due to its increasing antibiotic resistance.
- Accurate and rapid detection of resistance mechanisms is crucial for effective patient management and infection control.
Purpose of the Study:
- To develop and validate a microarray for the rapid and accurate detection of antibiotic resistance determinants in Acinetobacter baumannii.
- To reduce the diagnostic lead time for antibiotic resistance in A. baumannii.
Main Methods:
- Development of a microarray targeting 91 specific DNA sequences associated with antibiotic resistance.
- Validation of the microarray using 60 multidrug-resistant A. baumannii strains in a blinded, prospective study.
- Comparison of microarray results with phenotypic susceptibility testing (VITEK2) and PCR for carbapenemase genes.
Main Results:
- The microarray achieved high accuracy, with average positive predictive value of 98%, negative predictive value of 98%, sensitivity of 99%, and specificity of 94%.
- Complete concordance was observed when comparing microarray results for carbapenemase genes with singleplex PCR.
- The assay provides results within 4 hours from bacterial culture.
Conclusions:
- The developed microarray is a reliable tool for parallel detection of multiple antibiotic resistance determinants in A. baumannii.
- The rapid 4-hour turnaround time facilitates prompt initiation of appropriate anti-infective therapy for critically ill patients.
- The microarray has potential applications in clinical diagnostics and epidemiological surveillance of A. baumannii.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

